AAAAAA

   
Results: 1-17 |
Results: 17
CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia
Authors: Yang, XF Wu, CJ McLaughlin, S Chillemi, A Wang, KS Canning, C Alyea, EP Kantoff, P Soiffer, RJ Dranoff, G Ritz, J
Citation: Xf. Yang et al., CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia, P NAS US, 98(13), 2001, pp. 7492-7497
Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation
Authors: Teshima, T Mach, N Hill, GR Pan, LY Gillessen, S Dranoff, G Ferrara, JLM
Citation: T. Teshima et al., Tumor cell vaccine elicits potent antitumor immunity after allogeneic T-cell-depleted bone marrow transplantation, CANCER RES, 61(1), 2001, pp. 162-171
Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factoror interleukin-3
Authors: Tomasson, MH Williams, IR Li, SG Kutok, J Cain, D Gillessen, S Dranoff, G Van Etten, RA Gilliland, DG
Citation: Mh. Tomasson et al., Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factoror interleukin-3, BLOOD, 97(5), 2001, pp. 1435-1441
Interleukin 3 and granulocyte-macrophage colony-stimulating factor are notrequired for induction of chronic myeloid leukemia-like myeloproliferativedisease in mice by BCR/ABL
Authors: Li, SG Gillessen, S Tomasson, MH Dranoff, G Gilliland, DG Van Etten, RA
Citation: Sg. Li et al., Interleukin 3 and granulocyte-macrophage colony-stimulating factor are notrequired for induction of chronic myeloid leukemia-like myeloproliferativedisease in mice by BCR/ABL, BLOOD, 97(5), 2001, pp. 1442-1450
Overlapping roles for granulocyte-macrophage colony-stimulating factor andinterleukin-3 in eosinophil homeostasis and contact hypersensitivity
Authors: Gillessen, S Mach, N Small, C Mihm, M Dranoff, G
Citation: S. Gillessen et al., Overlapping roles for granulocyte-macrophage colony-stimulating factor andinterleukin-3 in eosinophil homeostasis and contact hypersensitivity, BLOOD, 97(4), 2001, pp. 922-928
Role of granulocyte/macrophage colony-stimulating factor in zymocel-induced hepatic granuloma formation
Authors: Wynn, AA Miyakawa, K Miyata, E Dranoff, G Takeya, M Takahashi, K
Citation: Aa. Wynn et al., Role of granulocyte/macrophage colony-stimulating factor in zymocel-induced hepatic granuloma formation, AM J PATH, 158(1), 2001, pp. 131-145
Genetically engineered cancer vaccines
Authors: Dranoff, G
Citation: G. Dranoff, Genetically engineered cancer vaccines, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 574-579
Nf1 and Gmcsf interact in myeloid leukemogenesis
Authors: Birnbaum, RA O'Marcaigh, A Wardak, Z Zhang, YY Dranoff, G Jacks, T Clapp, DW Shannon, KM
Citation: Ra. Birnbaum et al., Nf1 and Gmcsf interact in myeloid leukemogenesis, MOL CELL, 5(1), 2000, pp. 189-195
Cytokine-secreting tumor cell vaccines
Authors: Mach, N Dranoff, G
Citation: N. Mach et G. Dranoff, Cytokine-secreting tumor cell vaccines, CURR OP IM, 12(5), 2000, pp. 571-575
Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma
Authors: Heimberger, AB Crotty, LE Archer, GE McLendon, RE Friedman, A Dranoff, G Bigner, DD Sampson, JH
Citation: Ab. Heimberger et al., Bone marrow-derived dendritic cells pulsed with tumor homogenate induce immunity against syngeneic intracerebral glioma, J NEUROIMM, 103(1), 2000, pp. 16-25
Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors
Authors: Sampson, JH Crotty, LE Lee, S Archer, GE Ashley, DM Wikstrandt, CJ Hale, LP Small, C Dranoff, G Friedman, AH Friedman, HS Bigner, DD
Citation: Jh. Sampson et al., Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors, P NAS US, 97(13), 2000, pp. 7503-7508
Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia
Authors: Wu, CJ Yang, XF McLaughlin, S Neuberg, D Canning, C Stein, B Alyea, EP Soiffer, RJ Dranoff, G Ritz, J
Citation: Cj. Wu et al., Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia, J CLIN INV, 106(5), 2000, pp. 705-714
Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or flt3-ligand
Authors: Mach, N Gillessen, S Wilson, SB Sheehan, C Mihm, M Dranoff, G
Citation: N. Mach et al., Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or flt3-ligand, CANCER RES, 60(12), 2000, pp. 3239-3246
Interpreting cancer vaccine clinical trials
Authors: Dranoff, G
Citation: G. Dranoff, Interpreting cancer vaccine clinical trials, J GENE MED, 1(2), 1999, pp. 80-83
Cathepsin S required for normal MHC class II peptide loading and germinal center development
Authors: Shi, GP Villadangos, JA Dranoff, G Small, C Gu, LJ Haley, KJ Riese, R Ploegh, HL Chapman, HA
Citation: Gp. Shi et al., Cathepsin S required for normal MHC class II peptide loading and germinal center development, IMMUNITY, 10(2), 1999, pp. 197-206
CSF-1 regulation of Il6 gene expression by murine macrophages: a pivotal role for GM-CSF
Authors: Evens, R Shultz, LD Dranoff, G Fuller, JA Kamdar, SJ
Citation: R. Evens et al., CSF-1 regulation of Il6 gene expression by murine macrophages: a pivotal role for GM-CSF, J LEUK BIOL, 64(6), 1998, pp. 810-816
Granulocyte-macrophage colony stimulating factor based cancer vaccines
Authors: Dranoff, G
Citation: G. Dranoff, Granulocyte-macrophage colony stimulating factor based cancer vaccines, EUROCANCER 98, 1998, pp. 297-298
Risultati: 1-17 |